The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
July 7th 2025
The new formulation contains little IgA, reducing possible risks associated with infusion in patients with primary immunodeficiency.
Dasatinib Receives FDA Approval for Pediatric Ph+ Acute Lymphoblastic Leukemia
January 3rd 2019The FDA has approved dasatinib (Sprycel) tablets in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.
Read More